Fluidic device for producing platelets

1. A fluidic device ( 1 ) for producing platelets from a suspension of megakaryocytes ( 5 ), comprising:

a) a production chamber ( 3 ) comprising

b) at least one channel ( 8 ) delimited by non-porous walls,

c) at least one inlet opening ( 9 ) at one end in which a suspension of cells comprising megakaryocytes can be introduced and

d) at least one outlet opening ( 10 ) at the other end, in which platelets can be collected;

wherein at least one portion ( 11 ) of the inner surface of the walls of said channel ( 8 ) is textured with a plurality of obstacles.

2. The fluidic device according to claim 1 , wherein said textured portion ( 11 ) of the inner surface of the channel ( 8 ) is further coated with a ligand with binding affinity for megakaryocytes.

3. The fluidic device according to claim 1 , wherein the density, size and shape of said obstacles are determined so as to enable the capture of megakaryocytes on said textured portion of the inner surface of the channel for platelet shedding.

4. The fluidic device according to claim 1 , wherein the obstacles are posts ( 12 ) or beams ( 15 ).

5. The fluidic device of claim 1 , wherein said channel ( 8 ) has a substantially square or rectangular section.

6. The fluidic device of claim 1 , wherein the obstacles are posts ( 12 ) with a substantially circular cross-section of a radius r, and said posts are arranged on the inner surface ( 13 ) of at least one portion of said channel to form a regular pattern with a hexagonal periodic structure, wherein:

(i) the radius r is between 50 nm and 15 mm;

(ii) the closest distance p between two post centers is equal to 100 nm;

(iii) the angle a, which is the smallest angle defined by the longitudinal direction of the channel ( 14 ) and one of the lattice vectors of the hexagonal Bravais lattice is between 0 and 90°; and

(iv) optionally said posts have a height h<H, wherein H refers to the smallest distance measured between two opposite walls in a section of the channel.

7. The fluidic device according to claim 6 , wherein said channel has a height H that is between 5 μm and 1 mm.

8. The fluidic device according to claim 1 , wherein said production chamber ( 3 ) comprises at least one or a plurality of parallel channels with a textured portion on their inner surfaces.

9. An ex vivo method for producing platelets from megakaryocytes, said method comprising:

a) introducing a suspension of megakaryocytes into a fluidic device according to claim 1 ;

b) subjecting said suspension to a flow under a shear rate suitable for elongation, fragmentation of the megakaryocytes and platelet release in the channel of the production chamber; and

c) collecting platelets at the outlet of the channel.

10. The method according to claim 9 , wherein the flow rate is fixed within a range that subjects said megakaryocytes in the textured portion of the channel to a maximum wall shear rate γ max not exceeding 30000 s −1 .

11. The method according to claim 9 , wherein the collected platelets at the outlet of the channel further contain naked nuclei and/or intact megakaryocytes, said method further comprising the step of purifying, enriching or separating the platelets from said suspension.

12. The method according to claim 9 , wherein said suspension is a suspension obtained by the following steps: (i) providing megakaryocyte progenitor and/or stem cells, (ii) expanding said megakaryocyte progenitor and/or stem cells, and, (iii) differentiating the expanded cells into megakaryocytes.

13. The method of claim 12 , wherein the megakaryocyte progenitor and/or stem cells are selected from the group consisting of hematopoietic stem cells, embryonic stem cells and induced pluripotent stem cells.

14. The method according to claim 9 , wherein said suspension of megakaryocytes is homogenized and/or purified prior to entering in the production chamber.

15. The method according to claim 9 , wherein said platelets are sorted at the outlet of the channel by a method selected from the group consisting of cross flow filtration, laminar flow, dielectrophoresis, optical force, magnetic force, acoustic force, or inertial forces.

16. The method according to claim 9 , wherein said platelets are functional platelets which can be activated like circulating blood platelets.

17. The fluidic device according to claim 2 , wherein said ligand with binding affinity for megakaryocytes is selected from von Willebrand factor (VWF), or a biologically functional fragment thereof, or fibrinogen or fibronectin.

18. The method according to claim 10 , wherein said maximum wall shear rate does not exceed 10000 s −1 .

19. The method according to claim 10 , wherein said maximum wall shear rate does not exceed 8000 s −1 .

20. The method according to claim 10 , wherein said maximum wall shear rate does not exceed 5000 s −1 .

21. The fluidic device according to claim 6 , wherein the radius r is between 500 nm and 1.5 mm.

22. The fluidic device according to claim 6 , wherein the closest distance p between two post centers is between 100 nm and 50 mm.

23. The fluidic device according to claim 6 , wherein the closest distance p between two post centers is between 500 nm and 10 mm.

24. The fluidic device according to claim 6 , wherein the closest distance p between two post centers is between 5 μm and 1 mm.

25. The fluidic device according to claim 6 , wherein one of the lattice vectors of the hexagonal Bravais lattice is between 0 and 30°.

26. The fluidic device according to claim 8 , wherein said production chamber comprises between 2 and 106 channels.

27. The method according to claim 18 , wherein said maximum wall shear rate does not exceed 5000 s −1 .